Rising cancer numbers indicate urgent need for advancements in cancer research, and stem cell research is rising to meet the challenge. < ...

The market expects Iovance Biotherapeutics (IOVA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known ...

Session: Poster Session B Abstract title:Combination immunotherapy with an albumin-binding interleukin-12 fusion protein that extends cytokine half-life, targets the tumor microenvironment, and ...

Shares of Arcutis Biotherapeutics, Inc. (ARQT) have gained 0.8% over the past four weeks to close the last trading session at $12.78, but there could still be a solid upside left in the stock if short ...

A Philadelphia biotechnology company founded seven years ago by two former Johnson & Johnson executives has a new leader.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BridgeBio Pharma (BBIO – Research Report) and ...

PRINCETON, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company ...